《电鳗财经》电鳗号/文在医药行业跑马圈地的浪潮中,华润医药的并购版图不断扩大。2025年中报显示,其营收同比增长2.5%至1318.67亿元,净利润却反向下降。华润医药是中国领先的综合医药公司,业务范畴覆盖医药及保健产品的生产、分销及零售。华润医药成立于2007年,现已发展成中国第二大医药制造商兼中国第三大医药产品分销商(按收益)。华润医药的制造业务涵盖研发、生产及销售医药及保健产品。公司生产...
Source Link《电鳗财经》电鳗号/文在医药行业跑马圈地的浪潮中,华润医药的并购版图不断扩大。2025年中报显示,其营收同比增长2.5%至1318.67亿元,净利润却反向下降。华润医药是中国领先的综合医药公司,业务范畴覆盖医药及保健产品的生产、分销及零售。华润医药成立于2007年,现已发展成中国第二大医药制造商兼中国第三大医药产品分销商(按收益)。华润医药的制造业务涵盖研发、生产及销售医药及保健产品。公司生产...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.